par Stephan Lust | Juil 7, 2020 | Global Drug Facility, Global Fund, Johnson & Johnson, News, Stop TB Partnership, USAID
On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis medicine bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped...
